Please assess the completion status of the following clinical trial:

Trial Title: Intra Articular Injection of Microfat and PRP in Knee Osteoarthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Males and females between 20 to 65 years of age~* Symptomatic knee osteoarthritis , ICRS grade 2, 3 ou 4 with VAS \> 4 and failure of medical treatment for at least one year~* BMI between 20 to 30~* Written informed consent, signed by patient or legal representative~* HB \> 10g/dl~* Negative pregnancy test~* Social security affiliated~Exclusion Criteria:~* IRM contre-indications: ocular loose bodies, pace maker, neurostimulateur, cochlear implant, vascular clips, mettalic cardiac valve~* BMI \< 20~* Thrombocytopenia \< 150 G/L~* Thrombocytosis \> 450 G/L~* Thrombopathy~* TP \< 70%~* TCA patient / witness rapport \> 1,20~* Anaemia: HB \< 10g/dl~* Positive serology VIH1 and 2, Agp24, Ac HCV, Ag HbS, AcHbc, Ac HTLV I and II, TPHA~* Treatment by platelet inhibiting agent, aspirin, anti vitamin K completed more than 2 weeks before inclusion~* Chronic treatment by corticosteroid per os or treatment completed more than 2 weeks before inclusion~* Intra articular knee injection of corticosteroid more than 8 weeks before inclusion~* Intra articular knee injection of hyaluronic acid more than 8 weeks before inclusion~* NSAI treatment completed more than 2 weeks before inclusion~* Fever or recent disease~* Auto immune disease~* Inflammatory Arthritis~* Immune deficit~* Infectious disease~* Malignant tumor being treated or history of malignant tumor

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Microfat + PRP 3M platelets (Type: EXPERIMENTAL): microfat (5 ml) associated with PRP with a dose of 3 billions of platelets (5 ml)
- Microfat + PRP 1M platelets (Type: EXPERIMENTAL): microfat (5 ml) associated with PRP with a dose of 1 billion of platelets (5 ml)
- Microfat (Type: EXPERIMENTAL): microfat (5 ml) and saline solution (5 ml)

Based on this trial design, predict the completion outcome and termination type (if applicable).